Advertisement

Topics

Open Therapeutics Company Profile

11:12 EST 12th December 2017 | BioPortfolio

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global scientific community. The global research community can freely access the biotechnologies and funding to further the development of the biotechnologies at Therapoid™ (https://Therapoid.net). The Company is headquartered in Minneapolis, MN, with laboratory operations in Covington, Kentucky, Cincinnati, OH, Amman, Jordan, and Bangalore, India.


News Articles [802 Associated News Articles listed on BioPortfolio]

These 9 companies made it to the FDA’s pilot digital health program (Updated)

The picks span telecom giants to medtech companies but also include smaller companies with novel technologies such as digital therapeutics developer Pear Therapeutics and Tidepool — an open sou...

Lupin Primes For Specialty Future With Symbiomix Acquisition

Lupin has snapped up Symbiomix Therapeutics in the US as it gears to evolve it business from a straight generics...   

TG Therapeutics, Inc. Announces the Phase 3 ULTIMATE Trials Evaluating TG-1101 in Patients with Multiple Sclerosis Are Now Open for Enrollment

NEW YORK, Sept. 15, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that enrollment is now open for the Phase 3 ULTIMATE I and II trials.  ULTIMATE I and II are two ...

Medicare Monday: Open enrollment is here again

It’s that time of year again: Medicare open enrollment! As of Sunday, October 15, newly qualified patients and current Medicare beneficiaries can review their coverage options and selec...

The Open Patient: Advocating for open access to medical data

In The Open Patient: Healing through sharing, a new documentary from Red Hat Videos, Steven Keating and Liz Salmi share their personal stories about advocating for open medical data.

TG Therapeutics Announces The Phase III ULTIMATE Trials Evaluating TG-1101 In Patients With Multiple Sclerosis Are Now Open For Enrollment

  Life Sciences Jobs   ...

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Three Bentham Open Journals indexed in The Emerging Sources Citation Index (ESCI)

(Bentham Science Publishers) The Emerging Sources Citation Index (ESCI) has accepted to index three Open Access journals published by Bentham Open. The titles recently accepted to be indexed are: The ...

PubMed Articles [1148 Associated PubMed Articles listed on BioPortfolio]

The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma.

To assess intraocular pressure (IOP), systolic, diastolic, and mean arterial blood pressure (SBP, DBP, MAP) changes in the sitting, supine, and 20° head-down (Trendelenburg) position in treated (tPOA...

Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization.

To determine the frequency and economic impact of changing initial glaucoma therapy for patients with newly diagnosed open-angle glaucoma (OAG) or ocular hypertension (OHT).

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.

Infliximab (IFX) combined with azathioprine (AZA) is more effective than IFX monotherapy in inflammatory bowel disease (IBD).

Developing international open science collaborations: Funder reflections on the Open Science Prize.

The Open Science Prize was established with the following objectives: first, to encourage the crowdsourcing of open data to make breakthroughs that are of biomedical significance; second, to illustrat...

Response to Aslankurt et al. re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model".

Clinical Trials [1352 Associated Clinical Trials listed on BioPortfolio]

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1601 Associated Companies listed on BioPortfolio]

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Open Source Initiative (OSI)

Open Source Initiative (OSI) is a non-profit corporation dedicated to managing and promoting the Open Source Definition for the good of the community, specifically through the OSI Certified Open Sourc...

Open Health Tools

Open Health Tools is a nonprofit organization that promotes the availability of open technologies in healthcare worldwide. With over 60 members, OHT is transforming the global mar...

Open eHealth Foundation

Open eHealth Foundation (OeHF), launched at HIMSS 08, uses existing open source projects for developing a platform on which its members and other providers can create open source components that a...

eZ systems

Enterprise Open Source eZ systems is the creator of eZ publish, an Open Source Enterprise Content Management System. With an enterprise Open Source business model, we combine enterprise software with ...

More Information about "Open Therapeutics" on BioPortfolio

We have published hundreds of Open Therapeutics news stories on BioPortfolio along with dozens of Open Therapeutics Clinical Trials and PubMed Articles about Open Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Open Therapeutics Companies in our database. You can also find out about relevant Open Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record